The business of communicating science: a winning formula.
Though not widely recognised, the UK is a world leader in the business of global scientific and medical communications.
This success is founded on the historic partnership of scientific innovation, creativity and a strong pharmaceutical industry, which together provide the basis for a powerful business offering. Multi-way channels of communication between the pharmaceutical industry, medical and scientific communities, healthcare regulators and patients are essential for the success of the medicines and devices that underpin improvements in healthcare.
Chameleon has been at the forefront of connecting these communities for over a decade, as reflected by the recognition of Chameleon Communications International in this year’s Queen’s Awards for Enterprise. Since 1997, owners Angela Franklin and Gary Hobbs and their specialist teams of talented scientists and business experts have helped communicate the science behind advances in life-changing medicines. Chameleon’s education programmes have expanded understanding in areas such as the management of cancer, stroke prevention, diseases of the retina and Alzheimer’s. Chameleon teams in London, Manchester, New York, Basel and soon Berlin deliver communication solutions that reach across the globe from Asia-Pacific, East and West Europe, to North and South America. Chameleon is proud to be at the leading edge of scientific and medical education that has the potential to change the way medicine is practiced.
CHAMELEON COMMUNICATIONS INTERNATIONAL LTD
40-44 Uxbridge Road, London
W5 2BS UK
Tel: +44 (0) 208 326 3100
Creating a world of connections: Gary Hobbs and Angela Franklin